Religious, spiritual statements during ICU goals-of-care discussions important
the ONA take:
Among a cohort of surrogate decision makers who view religion or spirituality as an important consideration near the end of life of the patient, discussion of religious or spiritual considerations occurred in fewer than 20% of goals-of-care conferences in intensive care units, according to a new study published online ahead of print in JAMA Internal Medicine.
For the study, researchers at the Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center at the University of Pittsburgh School of Medicine in Pittsburgh, PA, sought to determine how often healthcare professionals and surrogate decision makers discuss religious or spiritual considerations during family meetings.
Researchers analyzed data from 249 goals-of-care conversations conducted between 651 surrogate decision makers and 441 health care professionals in institutions across the United States. Results showed that only 16.1% of the 249 conversations included discussion of religious or spiritual considerations.
Researchers found that in 15 conversations, health care professionals redirected religious or spiritual conversations to medical considerations, and in only 8 conversations did health care professionals ask further questions regarding the patient or family's beliefs.
Discussion of religious or spiritual considerations occurred in fewer than 20% of goals-of-care conferences in intensive care units.
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Immune Thrombocytopenia (Fact Sheet)
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|